GlassScriptPhysician profile
Heather C Beraducci
NPI 1174779821
$3,041.48
in general payments reported to CMS, 2019-2025
20 companies · $441 in 2025
The $441 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $930 · 2022: $528 · 2023: $530 · 2024: $613 · 2025: $441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,583.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $722.96 | 2021-2025 | Interstim |
| W. L. Gore & Associates, INC. | $506.16 | 2021-2025 | Gore Excluder Iliac Branch Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo, Excluder Conformable Aaa Endoprosthesis With Active Control |
| E.R. Squibb & Sons, L.L.C. | $291.05 | 2021-2024 | Eliquis |
| Janssen Pharmaceuticals, INC | $276.74 | 2021-2022 | |
| Cvrx, INC. | $208.83 | 2024 | Barostim Neo System |
| Abbott Laboratories | $167.19 | 2021-2025 | Esprit, Tacticath Ablation Catheter, Sensor Enabled |
| Astrazeneca Pharmaceuticals LP | $151.86 | 2021-2022 | |
| Madrigal Pharmaceuticals | $150.00 | 2025 | Rezdiffra |
| Baxter Healthcare | $133.18 | 2021-2025 | Perclot, Tisseel |
| Amgen INC. | $120.09 | 2021 | |
| Ethicon US, LLC | $85.68 | 2021-2025 | Dermabond Prineo, Stratafix |
| Convatec INC. | $50.67 | 2025 | |
| Karl Storz Endoscopy-America | $35.67 | 2022-2025 | Na |
| Boston Scientific Corporation | $30.83 | 2024 | Varithena Administration Pack |
| Bsn Medical INC | $20.70 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $20.10 | 2024 | Prevena, V.A.C.Instill |
| Kci USA, INC. | $19.68 | 2023 | Prevena |
| Cardiovascular Systems INC. | $17.85 | 2022 | |
| Smith+Nephew, INC. | $16.27 | 2024 | Collagenase Santyl |
| Pfizer INC. | $15.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Beraducci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.